ArticleFrontiers in pharmacology2026
Targeting PKLR and lipogenic enzymes through JNK inhibition to develop a therapeutic strategy for MASLD and MASH.
Woonghee Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
ArticleFrontiers in pharmacology2026
Woonghee Kim et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.